Search For "microfluidic"
Russian scientists create unique device for treatment of glioblastoma
Updated : 7 months, 1 week ago IST
Russian scientists have created a microfluidic platform that replicates blood flow in the brain. It is capable of supporting the vital activity of glioblastoma cells, one of the most aggressive forms of brain cancer that is difficult to treat.
Read More
Premas Life Sciences and Sphere Bio Unite to Advance Single-Cell Research
Updated : 10 months, 1 week ago IST
New Delhi [India], May 6: Premas Life Sciences Pvt. Ltd. (PLS), a pioneering enabler of life science innovations in India, has announced a strategic collaboration with Sphere Bio, a global leader in picodroplet-based microfluidic technologies for functional single-cell analysis. This partner
Read More
IIT Guwahati researchers use microfluidics to study how primary roots abso
Updated : 1 year, 7 months ago IST
The system has demonstrated that optimising nutrient flow can improve root growth and nitrogen uptake, leading to enhanced crop yields, as per a press release.
Read More
Study suggests how cancer spreads to the brain
Updated : 2 years, 11 months ago IST
Options for treatment are limited when cancer spreads to the brain. The majority of medications made to fight metastases either cannot penetrate the blood-brain barrier or are ineffective against brain metastases.
Read More
Microfluidic squeezing technology can treat head, neck cancer: Research
Updated : 3 years ago IST
Over the past ten years, an increase in head and neck malignancies has been related to human papillomavirus (HPV). For instance, studies show that 70 per cent of oropharyngeal cancer occurrences in the US are caused by HPV.
Read More
Study finds microfluidic squeezing technology to treat head, neck cancer
Updated : 3 years ago IST
Human papillomavirus (HPV) has been linked to a rising number of head and neck cancers over the past ten years. For instance, research indicates that HPV is responsible for 70 per cent of oropharyngeal cancer cases in the US.
Read More
LumiraDx launches Rapid Microfluidic Immunoassay C-Reactive Protein Test t
Updated : 3 years, 3 months ago IST
Mumbai (Maharashtra) [India], November 24 (ANI/NewsVoir): LumiraDx Healthcare Private Limited, a next-generation point of care diagnostics testing company announced it has launched its highly sensitive C-Reactive Protein (CRP) point of care antigen test across India.
Read More
Study finds how human tissue models can be used to improve treatment, diag
Updated : 3 years, 6 months ago IST
Washington [US], August 30 (ANI): A heart attack, also known as a myocardial infarction, is one of the main causes of death globally, accounting for 18 million death each year. These figures are projected to rise in the coming years as a result of COVID-19, according to a study.
Read More
Hybrid sensor developed by researchers for better cancer diagnosis
Updated : 3 years, 8 months ago IST
Washington [US], June 19 (ANI): A team of researchers from HSE University, Skoltech, MPGU, and MISIS have developed a nanophotonic-microfluidic sensor whose potential applications include cancer detection, monitoring and treatment response assessment.
Read More
Research shows development of hybrid sensor to help diagnose cancer
Updated : 3 years, 9 months ago IST
Moscow [Russia], June 18 (ANI): A research team from HSE University, Skoltech, MPGU and MISIS has developed a nanophotonic-microfluidic sensor whose potential applications include detection, monitoring and assessment of treatment success. Today, the device can identify dissolved gases and li
Read More
Study finds method to diagnose Lyme disease within 15 minutes
Updated : 6 years, 5 months ago IST
Washington D.C. [USA], Oct 13 (ANI): Researchers have developed a new treatment method capable of detecting Lyme disease in just 15 minutes.
Read More
New microfluidics device can detect cancer cells in blood
Updated : 7 years ago IST
Washington D.C. [USA], Feb 26 (ANI): Researchers have now developed a device that can isolate individual cancer cells from patient blood samples.
Read More